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Abstract
Intra-mammary bacterial infections can result in harmful clinical mastitis or subclinical mastitis with persistent infections.
Research during the last decades closely examined the pathophysiology of inflamed udders. Initial events after pathogen
perception but before the onset of mastitis have not been examined in vivo. The objective of this study was to develop a
mastitis model in cows by monitoring initial transcriptional pathogen-specific host response before clinical signs occur.
We applied a short-term infection model to analyse transcripts encoding chemokines, cytokines and antimicrobial
molecules in the teat cistern (TC) and lobulo-alveolar parenchyma (LP) up to 3 h after challenge with E. and
Staphylococcus aureus. Both pathogens elicited an immune reaction by 1 h after challenge. Escherichia coli induced all
analysed factors (CCL20, CXCL8, TNF, IL6, IL12B, IL10, LAP, S100A9); however, S. aureus failed to induce IL12B, IL10, LAP
and S100A9 expression. The E. coli-induced up-regulation was 25–105 times greater than that after S. aureus challenge.
Almost all the responses were restricted to the TC. The short-term mastitis model demonstrates that a divergent
pathogen-specific response is generated during the first h. It confirms that the first transcripts are generated in the TC
prior to a response in the LP.
Keywords
Cow, mastitis, subclinical, host-response, model
Date received: 12 November 2015; revised: 18 February 2016; accepted: 19 February 2016
Introduction
Intra-mammary bacterial infection is a common yet
unresolved problem in dairy cows. It can cause clinical
mastitis accompanied by an excessive inflammatory
response or subclinical mastitis with persistent infec-
tions.1 These different clinical pictures of disease are
often related to the species of the causative pathogen.
Intra-mammary infection with Escherichia coli usually
leads to clinical mastitis associated with visible changes
in milk, swelling and pain of the udder, and possibly a
systemic inflammatory response syndrome severely
affecting the cow.2 In contrast, Staphylococcus aureus
mostly accounts for subclinical mastitis lacking any vis-
ible signs of inflammation in the udder but leading to
long-term losses through high milk somatic cell counts
(SCC), reduced milk quality and quantity and an
increased risk of spreading the pathogen within the
herd.3,4
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Mastitis still accounts for most of the use of anti-
microbial drugs in dairy cows, despite considerable
research efforts over the last decades.5 Recently,
better understanding of host–pathogen interaction has
revealed that the clinical outcome of mastitis is decided
at the stage of pathogen recognition.6–8 This new know-
ledge about the molecular nature and activation time
points of defence mechanisms is crucial for the devel-
opment of new therapeutic and prophylactic concepts
aiming at modulating the cow’s immune response to
mastitis pathogens.
Owing to their sheer abundance in the udder, mam-
mary epithelial cells (MEC) and the lobulo-alveolar par-
enchyma (LP) have predominantly been studied with
regard to host response during bovine mastitis. The
teat and the gland cistern and its associated tissues
have recently been the subject of several studies.9–11
It has been shown that during early stages of infection
the transcriptional response is greater in these tissues
compared with the LP, demonstrating a sentinel
function within these distal compartments of the mam-
mary gland.
The immune response in the udder is dominated by
factors of innate immunity.1 Regardless of the model
system applied to analyse the host response, E. coli was
always found to trigger a strong inflammatory response
in the udder and MEC, while the response to S. aureus
was always significantly weaker.6,12,13 Changes in the
abundance of mRNA transcripts of immune-related
genes are among the first host-associated events after
pathogen invasion and recognition.14 Differentially
expressed genes in the early stages of infection mostly
encode distinct cytokines, chemokines and antimicro-
bial peptides.9,15
Previous infection models sequentially challenged
several udder quarters of the same animal at different
times, allowing the analysis of different stages of intra-
mammary infection and host response within one
animal.9,10,13 However, at the time of tissue sampling
these animals were already affected by clinical and sub-
clinical mastitis. Thus, the results were biased by the
systemic response of the host affecting all udder quar-
ters, independent of whether they were pathogen chal-
lenged or not. This ‘crosstalk’ between udder quarters
was more pronounced in animals affected by clinical E.
coli mastitis rather than subclinical mastitis caused by
S. aureus.14
Mastitis research during the last decades has closely
examined the pathophysiology of the inflamed mam-
mary gland. However, little is known about the first
transcriptional response before the disease becomes
apparent by clinical signs (fever, udder swelling) or
the increase of SCC in the milk. With regard to tran-
scriptional events during the first 3 h after pathogen
contact, knowledge is limited to in vitro experiments
with mammary cells or tissue explants.6,8,11 Early
stages of intra-mammary infection, in which pathogens
have already been recognized but no clinical signs have
yet appeared, have, up until now, not been satisfactor-
ily examined in depth in vivo.
The aim of this paper was to develop a sequential
mastitis infection model in cows uncovering the very
first transcriptional pathogen-specific host responses at
different time points of intra-mammary bacterial pres-
ence of E. coli and S. aureus before the occurrence of
clinical signs.With regard to a location-specific response
in the mammary gland, transcripts of genes known to be
among the first regulated ones in the MEC and LP after
pathogen contact should be analysed in different com-
partments of the teat and the udder.
Materials and methods
Animals
The animal experiments included 12 healthy, first-lac-
tating Holstein cows, 26–35mo of age and 59–185 d in
milk. The in vivo trials were conducted at the Clinic for
Ruminants, LMU Munich (Oberschleißheim,
Germany) with the approval of the ethics committee
of the regional government of Upper Bavaria,
Germany (No. 55.2-1-54-2531-102-09, 21st September
2009). Only animals without previous diagnosis of clin-
ical or subclinical mastitis and a reported SCC
<50,000/ml were included in the study. Before the
trial, weekly testing of quarter milk samples with a
Fossomatic 5000 (FOSS Electric, Hillerod, Denmark)
ensured that the milk contained <50,000 somatic cells/
ml and was free from pathogens as assessed by plating
15l milk on Columbia sheep blood agar, on Violet red
bile agar and on Edwards agar (all from Oxoid, Wesel,
Germany). During a minimum period of 3 wk before
the trial, the animals were transferred to the experimen-
tal unit (tie stall on straw) to guarantee an adequate
adaption phase to the new environment, including the
technical personnel. Three times per wk, the cows were
carefully examined by a veterinarian to attest to their
general health. They were milked twice daily at 12 h
intervals and were fed a total mixed ration based on
production level. To achieve comparable hormonal
conditions, all the animals were synchronized by inser-
tion of CIDR devices according to the manufacturer’s
specifications (Zoetis, Berlin, Germany) so that at the
time point of tissue sample collection all the animals
were at the stage of oestrus.
E. coli and S. aureus model strains
The bovine mastitis isolates E. coli 1303 and S. aureus
1027 were isolated from cases of clinical and subclinical
mastitis, respectively, and have previously been used in
different in vivo and in vitro studies.6,13–15 The strain E.
coli 1303 belongs to the major E. coli phylogenetic group
A, and, based on a multiplex PCR screening for
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virulence-associated genes, it does not represent an
extra-intestinal or intestinal pathogenic E. coli isolate.
According to recent structural and genetic analyses, its
LPS represents a novel serotype and possesses the K-12
core type.16
The strain S. aureus 1027 is positive for mannite
cleavage, clumping factor and free coagulase.13
Furthermore, this strain represents the sequence type
133 and the agr-type 1 and expresses leukocidine
[lukF-PV(P83)/lukM] but no superantigens.17
The second passage of the original isolates was kept
cryo-conserved (Mikrobank-System Cryobank; Mast
Diagnostika, Reinfeld, Germany) for subsequent prep-
aration of the inoculum dose. The latter was prepared
as previously described.18 Bacteria were plated on
Columbia sheep blood agar (Oxoid) and incubated
(37C) for 24 h. A few colonies were transferred to a
tube of brain–heart infusion broth (Oxoid) and incu-
bated for 6 h (37C); then, a 100-l sample was trans-
ferred to a tube containing 9.9ml trypticase soy broth
(Oxoid). Serial dilutions were made after 18 h to pre-
pare the desired inoculum dose of 5 106CFU/
2ml 0.9% sterile, pyrogen-free saline.
Intra-mammary pathogen challenge
A schematic overview of the sequential intra-mammary
challenge model is given in Figure 1. The animals were
randomly applied to two different treatment groups. In
the Ec3h group six cows were experimentally challenged
with E. coli, and in the Sa3h group six cows were chal-
lenged with S. aureus. At trial start the udder was
entirely milked out after i.v. application of 20 IU
Oxytocin (Veyx-Pharma, Schwarzenborn, Germany).
After cleaning and disinfecting the teat end thoroughly
with 70% ethanol, the first challenge dose (5 106CFU/
2ml) was instilled into the hind left quarter intra-cister-
nally with a sterile syringe and teat cannula via the teat
canal. To avoid any unwanted loss of the instilled chal-
lenge dose, the teat canal was kept closed by two fingers
during removal of the teat cannula. The teat and the
udder were not massaged after applying the challenge
dose. One h after trial start, the front left udder quarters
were challenged; another h later the hind right quarters
were challenged as described above. The front right
quarters received no challenge and are referred to as
control quarters. The trial ended 3 h after the first chal-
lenge. At this time point the duration of pathogen pres-
ence was 1 h for hind right quarters, 2 h for front left
quarters and 3 h for hind left quarters.
Monitoring local and systemic clinical signs of
mastitis
Throughout the trial a complete clinical examination of
the animals was carried out in 1-h intervals to guaran-
tee that none of the animals showed either local or
systemic signs of mastitis. In addition to monitoring
rectal temperature, heart rate, rumen contraction rate,
appetite and general attitude every h, the udder was
examined for swelling of the parenchyma, subcutane-
ous oedema, rise in temperature on the udder surface
compared with neighbouring quarters and signs of
quarter pain. Milk secretion was macroscopically
checked for alterations (clots, colour, consistency) at
trial start and trial end. Simultaneously, quarter milk
samples were aseptically collected in sterile vials for
bacteriological examination. Fifteen l quarter milk
samples were plated on Columbia sheep blood agar,






























Figure 1. Experimental set-up of intra-mammary E. coli and S.
aureus challenge. Three of four quarters per animal were
sequentially inoculated with either 5 106 CFU E. coli (n¼ 6,
group Ec3h) or 5 106 CFU S. aureus (n¼ 6, group Sa3h) for 1, 2
and 3 h. One control quarter (front right quarter) remained
untreated and was used to measure baseline expression values.
The animals were culled 3 h after inoculation of the first udder
quarter and tissue samples from the TC, GC and LP were taken
for RT-qPCR analysis.
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to exclude any unwanted bacterial growth during the
trial period. The plates were incubated for 48 h at 37C
and were examined daily for bacterial growth. At trial
start and trial end, the animals were milked with a
quarter milker (WestfaliaSurge, Bönen, Germany) so
that the milk from individual udder quarters was col-
lected in separate containers.
Bacterial recovery from milk
At trial end, 10ml milk was collected from every sep-
arate container of the quarter milker. These samples
served to determine the exact amount of CFU of inocu-
lated pathogens within the whole milk fraction of a
quarter. A dilution series was made with sterile 0.9%
saline and the dilutions 101–103 were plated on
selective media. For the samples from the Ec3h
group, the dilutions were plated on Violet red bile
agar, and the dilutions from the Sa3h group were
plated on Baird-Parker-Agar (Oxoid). After incubating
for 24 h at 37C, the plates were examined for bacterial
growth, and the colonies were counted, using an auto-
mated colony counter (‘Flash and Grow’) with the soft-
ware Flash & Go, version 1.0 (both IUL Instruments,
Königswinter, Germany). To calculate the amount of
CFU/udder quarter milk at trial end, the determined
CFU/ml milk was multiplied by the absolute amount of
milk gained from the udder quarters at trial end.
Sampling of blood and tissue
Blood samples (10ml) were taken from the jugular vein
aseptically using EDTA-Vacutainers (Becton
Dickinson, Heidelberg, Germany) at trial start and
trial end. Leukocyte counts in the blood samples were
carried out with a Sysmex pocH100i (Sysmex,
Norderstedt, Germany). At trial end, the cows were
slaughtered with a penetrating captive bolt gun, fol-
lowed by exsanguination. Tissue samples were collected
aseptically from the locations in the teat cistern (TC),
gland cistern (GC) LP from the slaughtered cows
within 10min after killing, as shown in Figure 1.
Small tissue pieces (0.5 0.5 0.5 cm) were taken
from each location after the right and the left udder
side was cut open sagittally. All tissue samples were
immediately snap frozen in liquid nitrogen and stored
at 80C until further processing.
RNA extraction and RT-qPCR
Tissue samples from the TC, GC and LP (50–200mg)
were powdered under liquid nitrogen. RNA was subse-
quently extracted with TRIzol (Invitrogen, Karlsruhe,
Germany) and column-purified (RNeasy; Qiagen) and
contaminating DNA was removed (DNase I digestion;
Qiagen). RNA concentration was measured with a
Nanodrop device and the quality was assessed by
denaturing agarose gel electrophoresis and ethidium
bromide staining. The cDNA was generated with the
Superscript II reverse transcriptase (Invitrogen) follow-
ing the general reaction conditions as prescribed for
using this enzyme. We supplemented 1 mg total RNA
and pooled the gene specific reverse primers for all
target genes, column-purified the resulting cDNA after
the reaction and distributed aliquots equivalent to 75 ng
total RNA input into the cDNA reaction into individual
vials. These were subsequently used for quantification of
the cDNA copy numbers by RT-qPCRwith the with the
LightCycler instrument and the SYBR Green plus
reagent kit (both from Roche, Basel, Switzerland),
essentially as described.19 Copy numbers were titrated
against external standards for every gene consisting of
dilution series (106–10 copies) of clones harboring the
respective amplicon. Values were depicted as cDNA
copy numbers relative to the RNA quantity used as
input for the RT-qPCR determination. Sequences of
the oligonucleotide primers used are given in Table 1.
Statistical analysis
The data were entered into Excel (Microsoft Inc.,
Redmond, WA, USA) and analysed using Excel
(Microsoft), Origin (Version 8; OriginLab Inc.,
Northampton, MA, USA), SAS (Version 9.2; SAS
Inc., Cary, NC, USA) and PAST (Version 1.89;
Palaeontological Statistics, Oslo, Norway).
Description of the data using mean, median, SD, min-
imum and maximum was performed in Excel. Assessing
the normality of the data was performed visually using
box-and-whisker-plots, as well as Q-Q-plots. As not all
the data were normally distributed, non-parametric
tests were used to compare parameters between the
two different treatment groups at each individual
point in time (Mann–Whitney U-tests).
Within each group the parameters for temperature,
leukocytes, bacterial counts at each point in time and
the candidate gene expression were compared between
the different time points and sampling locations using
non-parametric paired tests (Wilcoxon test). A t-test
was used to compare the absolute cell counts in the
different quarters.
A mixed model (Proc MIXED in SAS) was used to
compare the course of the candidate genes, taking into
account the repeated measures within the animals,
which were considered as a random effect. The signifi-
cance level was set to P< 0.05.
Results
The absence of clinical signs of mastitis is achieved
within the challenge period of 3 h
After intra-mammary challenge with 5 106CFU E.
coli or S. aureus none of the animals displayed any
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clinical response (Figure 1). There was no elevation in
body temperature or alteration of blood leukocytes
detectable within the 3-h period between the beginning
and the end of the trial, indicating an absence of signifi-
cant systemic reactions (Table 2). Furthermore, the milk
appearance and the SCC remained unchanged, and
there were no signs of udder swelling (data not shown).
E. coli multiplies faster than S. aureus during the
first 3 h after pathogen inoculation
During the 3 h period of the challenge trial, the animals
of the E. coli challenged group (Ec3h) showed a signifi-
cant increase in E. coli bacterial counts in milk, depend-
ent on the duration of pathogen challenge, whereas the
trend of S. aureus multiplication in the milk of the ani-
mals from the S. aureus challenged group (Sa3h) was
not significant (Figure 2). E. and S. aureus could be
recovered from every challenged quarter and there was
no growth of other bacteria at any time point of exam-
ination before or after the challenge trial nor in the milk
of any of the control quarters (data not shown).
E. coli elicits a more vigorous early immune
reaction than S. aureus
The mRNA copy numbers of the candidate genes mea-
sured in the tissue of the teat and the udder are given in
Figures 3–5. All the animals displayed a transcriptional
response to intra-mammary challenge with either E. coli
or S. aureus. This response could already be found in
the tissue of the quarters that had been exposed to
pathogens for only 1 h. The animals that had received
the E. coli challenge responded with up-regulation of all
the analysed chemokines (CCL20, CXCL8; Figure 3),
cytokines (TNF, IL6, IL12B, IL10; Figure 4) and anti-
microbial effector molecules (LAP, S100A9;
Figure 5). S. up-regulated the chemokines CCL20
and CXCL8 (Figure 3), and the cytokines TNF and
IL6 (Figure 4), but failed to induce IL12B, IL10,
LAP and S100A9. Regarding the extent of regula-
tion, we note that E. coli induced a much stronger
up-regulation, exceeding that of S. aureus by 25-fold
(TNF), 52-fold (CCL20), 76-fold (CXCL8) and 105-
fold (IL6).
Table 1. Oligonucleotide primers and fluorescence acquisition temperature for RT-qPCR.
Gene GenBank no. Primer sequence (50–30) Amplificate size (bp) Temperature (C)
CCL20 NM_174263.2 CAGCAAGTCAGAAGCAAGCAA 179 80
CCCACTTCTTCTTTGGATCTGC
CXCL8 NM_173925 CCTCTTGTTCAATATGACTTCCA 170 81
GGCCCACTCTCAATAACTCTC
TNF NM_173966.2 CTTCTGCCTGCTGCACTTCG* 156 84
GAGTTGATGTCGGCTACAACG*
IL6 NM_000600.3 GGAGGAAAAGGACGGATGCT 227 80
GGTCAGTGTTTGTGGCTGGA
IL12B NM_174356.1 TGGTCGTTTCCTGGTTTTCC 205 81
GTTTTGCCAGAGCCCAAGAC
IL10 NM_174088.1 GTGGAGAAGGTGAAGAGAGTC 176 79
CGTCATGGAGTCTAGTAGAGTC
LAP NM_203435 AGGCTCCATCACCTGCTCCTT 182 83
CCTGCAGCATTTTACTTGGGCT
S100A9 NM_001046328 CTCAAACAGAAGGCGGGAAA 225 80
TTGTGTCCAGATCCTCCATGA
Table 2. Rectal body temperature and blood leukocyte counts 0 h and 3 h after intra-mammary challenge with either 5 106 CFU E.
coli (Ec3h) or 5 106 CFU S. aureus (Sa3h).
Ec3h (n¼ 6) Sa3h (n¼ 6)
0 h 3 h 0 h 3 h
Blood leukocyte counts (*103/ml) 7.2 1.59 7.7 1.54 7.7 1.00 7.9 6.31
Rectal body temperature (C) 38.45 0.23 38.40 0.27 38.47 0.30 38.37 0.27
Data are shown as the mean SD. There were no statistically significant differences.
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TC and GC respond earlier and with a more
pronounced response to pathogens than LP
The TC and GC showed an equal response (data not
shown); thus, data are only given for the TC. In the
control udder quarters, which had received no patho-
gen challenge, the constitutive mRNA expressions of
S100A9, LAP, TNF and IL10 were significantly
higher in the tissue of the TC compared with the LP
(P< 0.013; Figures 4 and 5). This was independent of
the challenge group (Ec3h or Sa3h) to which the ani-
mals had been assigned.
The observed transcriptional response to E. coli and
S. aureus challenge was mainly limited to the tissue
from the TC. In the animals of the Sa3h group, there
was no detectable reaction in the LP. In the Ec3h
group, only the factors CXCL8 and TNF were slightly
up-regulated in the LP after 3 h of pathogen exposition
compared with the unchallenged control quarters (2.5-
and 4.0-fold, respectively). However, this up-regulation
was not statistically significant (P¼ 0.22 and 0.09,
respectively; Figures 3 and 4).
The sequential animal infection model displays
different stages of host response to E. coli and
S. aureus
The sequential challenge model reflected the induction
kinetics of the selected immune-related genes in the
early phase of mastitis in the TC (Figure 1). In the E.
coli-challenged animals, TNF, IL10, CCL20 and
CXCL8 were among the immediate early up-regulated
genes and had already reached a more or less distinctive
expression plateau 1 h after challenge (Figures 3 and 4).
The expression kinetics of IL6, IL12B, LAP and
S100A9 did not reach a plateau level during the chal-
lenge period (Figures 4 and 5). A gene-specific induc-
tion kinetic could not be observed after S. aureus
challenge. The significant induction in the TC of
TNF, IL6, CCL20 and CXCL8 reached a plateau
level in the 3-h challenge period, but the level of induc-
tion was much less marked than after E. coli challenge
(Figures 3 and 4).
Discussion
The pathogens E. coli and S. aureus play a major role in
clinical and subclinical mastitis, respectively. We
applied a novel short-term infection model to analyse
initial transcripts in the udder, dependent on time, loca-
tion and the causative pathogen. These analysed factors
are among the first genes regulated in the LP and MEC
after challenge with E. coli or S. aureus or their asso-
ciated molecules and are held responsible for shaping
the immune response towards these pathogens.6,8
By 1 h after pathogen challenge, E. coli had already
elicited a stronger transcriptional response of all the
examined genes than S. aureus in the TC. This obser-
vation is in line with all previous reports from in vivo
and in vitro experiments comparing the response
towards these two pathogens.6,12,14 However, up
until now, animal experiments comparing the response
to E. coli and S. aureus were limited to trials, where
signs of an inflammatory response were already pre-
sent with regards to either a systemic response (fever,
leukopenia) or a local response (udder swelling,
altered milk appearance, increased SCC). We vali-
dated that our new in vivo model, as presented here,
enabled us to analyse the initial response before any
signs of clinical and subclinical mastitis emerged. A
previous study had shown that by increasing the
dose of intra-mammary E. coli challenge, the period
to onset of clinical signs could be shortened.20 Based
on these observations, we applied a relatively high
challenge dose (5 106CFU) of either E. coli or S.
aureus into the udder to guarantee that the bacterial
load was sufficiently abundant to be recognized.
Furthermore, we kept the duration of the experiment
short enough to avoid the emergence of a clinical
response.
The mastitis pathogens E. coli and S. aureus differ in
their ability to multiply within the mammary gland
during infection.1 E. coli is known to multiply very
fast in milk and may display a generation time of up
to 20min.2 This may be partially causative for the
observed differences in the pathogen-specific host
response in numerous studies. Within this study, we
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Figure 2. Bacterial counts in milk after intra-mammary E. coli
and S. aureus challenge. CFU of E. coli and S. aureus 1, 2 and 3 h
after intra-mammary challenge of 6 animals, respectively. The
bars display the amount of CFU/udder quarter milk, which were
determined by multiplying the CFU/ml milk with the absolute
amount of milk gained from the udder quarters at trial end. The
dotted line displays the amount of CFU (5 106) used for
intra-mammary challenge. Different letters denote statistically
significant differences between different time points of pathogen
presence (P< 0.05).
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strain significantly multiplied, while there was no sig-
nificant increase of S. aureus in the milk of the
challenged cows during the first 3 h after challenge
(Figure 2). This may have accounted for the more vig-
orous response of the E. coli challenged cows; however,
in udder quarters challenged for only 1 h, a comparable
bacterial load of E. coli and S. aureus elicited a much
stronger response in the tissues of the E. coli challenged
animals (Figures 2–5).
Our study shows that both applied pathogens ini-
tially elicit a transcriptional response in the TC but
not in the LP (Figures 3–5). This points to a time-
and compartment-dependent response induction after
intra-mammary challenge. Because the TC is
confronted earlier than the LP with invading patho-
gens, a more rapid response was expected. The present
but comparably weak response to S. aureus challenge
was limited to the tissue of the TC, and there was no
significant regulation of the analysed transcripts in the
LP. This observation demonstrates the necessity for
applying multiple sampling locations of tissue in mas-
titis infection trials, as previously demonstrated. It was
shown that the host response in the udder towards E.
coli 12 h after challenge was mostly found in the tissues
of the teat and gland cistern; although, in contrast to
our study, these animals were already affected by clin-
ical mastitis.9 We could confirm this observation for the
E. coli and also for the S. aureus-challenged animals;
E. coli S. aureus























































































































































Figure 3. Gene expression profiles of chemokines after RT-qPCR analysis of tissue from the TC and LP after intra-mammary
challenge of six animals with either 5 106 CFU E. coli (group Ec3h) or 5 106 CFU S. aureus (group Sa3h). Each symbol represents
data derived from one individual animal (copy numbers/75 ng mRNA); the curved lines represent median values within the group.
Different letters denote statistically significant differences between time relative to challenge (P< 0.05).
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Figure 4. Gene expression profiles of cytokines after RT-qPCR analysis of tissue from the TC and LP after intra-mammary challenge
of six animals with either 5 106 CFU E. coli (group Ec3h) or 5 106 CFU S. aureus (group Sa3h). Each symbol represents data derived
from one individual animal (copy numbers/75 ng mRNA); the curved lines represent median values within the group. Different letters
denote statistically significant differences between time relative to challenge (P< 0.05).
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however, within the applied model system here we were
even able to show this location-specific response before
the onset of clinical signs. In a previous S. aureus chal-
lenge model, it was shown that the factors of the innate
immune response were up-regulated in a more pro-
nounced manner in the LP.10 However, sample collec-
tion was carried out 21 d after the first S. aureus
challenge, which possibly explains the differences in
the data of the present study.
All eight selected candidate genes were significantly
up-regulated in the TC after E. coli challenge. The
sequential challenge model allowed us to describe a
gene-specific kinetic of the immune gene induction
(Figure 1). Roughly two groups of genes could be dis-
tinguished: the first group (TNF, IL10, CCL20,
CXCL8) was characterized by an immediate early
induction, which rapidly reached a plateau level that
was sustained during the 3-h challenge period. This is
in line with previous reports where TNF, CCL20 and
CXCL8 were among the immediate early regulated
genes in bovine MEC.6 The subsequently induced
group of genes (IL6, IL12B, LAP and S100A9) did
not show a plateau level of mRNA copies during the
3-h E. coli challenge (Figures 4 and 5). The antimicro-
bial effectors LAP and S100A9 are known to be
late-induced genes in E. coli-stimulated MEC.6 The
cytokines IL6 und IL12B are well-known secondary
response genes,21 which require new protein synthesis
for their induction. In E. coli-stimulated MEC, IL6 is
among the delayed early induced inflammatory
response genes.6
Except for IL10, all the other immediate early
induced genes (TNF, CCL20 and CXCL8) were also
significantly up-regulated in the TC after S. aureus
challenge (Figures 3 and 4). Although the induction
level in the TC was only 1–7% compared with the
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Figure 5. Gene expression profiles of antibacterial effector molecules after RT-qPCR analysis of tissue from the TC and LP after
intra-mammary challenge of six animals with either 5 106 CFU E. coli (group Ec3h) or 5 106 CFU S. aureus (group Sa3h). Each
symbol represents data derived from one individual animal (copy numbers/75 ng mRNA); the curved lines represent median values
within the group. Different letters denote statistically significant differences between time relative to challenge (P< 0.05).
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E. coli-challenged animals, both pathogens elicited a
response within the first h after challenge. The strong
difference in the level of induction between E. coli and
S. aureus is in line with previous reports, where the S.
aureus-mediated induction in MEC was <5% com-
pared to the E. coli-mediated induction.6,7
In addition to CXCL8, TNF and CCL20, the cyto-
kine IL6 was significantly induced in the TC after S.
aureus challenge (Figure 4). The importance of this
delayed early cytokine for the inflammatory response
of the MEC after S. aureus stimulation has recently
been demonstrated.6 Although we were not able to
show within this study which cell types were responsible
for the induction of the gene transcripts, the induction
pattern of those four inflammatory factors in the TC
after S. aureus infection, including an absent induction
of IL-10, resembles the previously described response of
S. aureus-stimulated MEC and could now be demon-
strated in vivo.6 The observation suggests a major role
of the epithelial cells in the response against S. aureus in
the TC. However, after E. coli challenge, IL10 and
IL12Bwere also up-regulated in the TC. These cytokines
are reported to be primarily expressed by myeloid cells
(e.g. macrophages, dendritic cells) and T cells but not by
MEC,7,22 suggesting their contribution in the early
phase of the immune response in the TC against E. coli.
In addition to the strong induction of inflammation
related genes in the TC after E. coli challenge, we
observed the beginning (not significant) of the induc-
tion of the inflammatory cytokines TNF- and CXCL8
in the LP 3 h after E. coli challenge (Figures 3 and 4).
This suggests that within the 3-h timeframe after E. coli
challenge, the observed immediate early regulation of
these genes subsequently starts in tissue compartments
more distant to the site of pathogen entry and may be
caused by a later contact with the pathogens. Whether
the observed higher constitutive expression of S100A9,
LAP, TNF and IL-10 in the TC compared with the LP
in the untreated udder quarters were caused by a dif-
ferent cellular composition was not analysed within
this study (Figures 4 and 5). However, it underlines
the necessity for multiple sampling locations in mas-
titis in vivo trials. The higher expression of antimicro-
bial effector molecules (S100A9, LAP) in the TC
compared with the LP may act as a natural defence
mechanism against pathogens invading via the teat
canal. This is underpinned by a previous report show-
ing even higher constitutive expression levels of anti-
microbial S100-proteins in the Furstenberg’s rosette
compared with the TC.11
Experimental mastitis models with cows usually
involve very limited numbers of animals owing to com-
parably high expenses. Thus, individual differences in
the host response have a major impact on the achieved
results. Although the selection of comparable experi-
mental animals within this study was based on well-
proven and strict criteria,15 the transcriptional response
to intra-mammary challenge displayed a certain vari-
ance in the expression levels of the analysed genes. A
continuous pattern became obvious when individual
animals were classified with regard to expression
levels in the teat cistern. Animals with comparable
high levels of all the analysed genes in the Ec3h group
(animals 2 and 7, black symbols in Figures 3–5) con-
sistently showed the strongest transcriptional response
to E. coli challenge. Within the Sa3h group this could
also be observed in two animals for CCL20 and TNF
(animals 3 and 4, black symbols in Figures 3 and 4).
These animals also displayed the highest levels of LAP
after intra-mammary S. aureus challenge (Figure 5, ani-
mals 3 and 4). Whether this stronger transcriptional
response is related to a better defence against pathogens
in the udder could not be analysed within this study.
However, we previously showed that Holstein heifers
could be divided into ‘fast’ and ‘slow’ responding ani-
mals based on their SCC increase after intra-mammary
S. aureus challenge, and the ‘fast’ responding animals
cleared infection more effectively than the ‘slow’
responders.13
The interdependence of a transcriptional response
between udder quarters by systemic effects within one
animal have been shown to a high extent in E. coli-
challenged cows,15 and to a lesser extent during experi-
mental S. aureus mastitis.10,14,15 Thus, the data of the
intra-animal controls from uninfected udder quarters
must be interpreted with caution. Within the herein
presented sequential challenge model, crosstalk may
have affected the transcriptional response of the udder
quarters that received pathogen challenge for 1 or 2, or
no challenge. However, there was no difference in the
expression levels of the analysed genes in the unchal-
lenged quarters regardless of the challenge group (Ec3h
or Sa3h) to which the animals belonged, suggesting that
systemic effects were absent. Whether the onset of sys-
temic clinical signs (fever, leukopenia) would have been
coincidental with the transcriptional systemic effects
between udder quarters, while likely could not have
been shown within this study.
Altogether, the applied model is a suitable tool to
examine very early events during pathogen recognition
in the udder and may serve in the future for holistic
approaches to analyse the pathways of immune activa-
tion during the onset of clinical and subclinical mastitis.
In conclusion, this short-term model clearly
demonstrates that a pathogen specific response to
intra-mammary challenge is already generated at tran-
scriptional level during the first hour. It confirms that
the first transcripts in response to pathogenic threats
are generated in the tissues of the teat while a response
in the udder parenchyma is still absent. The typical
divergent host response patterns caused by E. coli and
S. aureus with regard to clinical and subclinical mastitis
are already reflected in quantity and quality at this early
stage in the teat.
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